Quantcast

Latest Personalized medicine Stories

2014-06-24 08:30:59

IRVING, Texas, June 24, 2014 /PRNewswire/ -- Valley Medical Oncology Consultants (VMOC) and Caris Life Sciences announced today a collaboration to establish a clinical molecular profiling program that enables more personalized treatment for cancer patients in the San Francisco Bay Area. This program will leverage the power of Caris Molecular Intelligence(TM), the industry's leading comprehensive tumor profiling service, to better target therapy options based on a patient's unique...

2014-06-24 08:29:45

Future revisions to in-vitro diagnostics laws will offset the launch of new tests, in a market expected to soar to $1,295.1 million in 2018 LONDON, June 24, 2014 /PRNewswire/ -- With the growth in personalised medicine, there is an increased interest in developing companion diagnostics (CDx) tests or tests that match the right therapy to the patient. In fact, over the past few years, market participants have been entering pharmaceutical and diagnostic partnerships in a bid to develop...

2014-06-19 23:05:31

Transparency Market Research published a new report "Cancer/Tumor Profiling Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" to its report store. Browse the full report: http://www.transparencymarketresearch.com/cancer-tumor-profiling.html. Albany, New York (PRWEB) June 19, 2014 Cancer is a fatal disease characterized by uncontrolled cell division. It is primarily caused by environmental factors that mutate the gene encoding for cell...

2014-06-16 08:29:23

DUBLIN, June 16, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/bqwbck/companion) has announced the addition of the "Companion Diagnostics Market (2nd Edition), 2014 - 2024" [http://www.researchandmarkets.com/research/bqwbck/companion ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The Companion Diagnostics Market (2nd Edition), 2014 - 2024' report provides an extensive study of the...

2014-06-15 23:00:10

Increasing government funding and technological advancements are expected to positively influence the Genomics market growth - http://www.marketsandmarkets.com/Market-Reports/genomics-market-613.html. (PRWEB) June 16, 2014 New analysis from MarketsandMarkets "Genomics Market by Products - [Instruments (NGS platform, Microarray, RT-PCR), Consumables (Genechips, Reagents for DNA Extraction & Purification, Sequencing)], Services (Sequencing & Microarray Services, and Software) -...

2014-06-13 08:23:50

LONDON, ON, June 13, 2014 /CNW/ - KalGene Pharmaceuticals, Inc. (KalGene) is expediting development of a prognostic marker and companion therapeutic that specifically targets aggressive cancers. "KalGene is focused on growth, with a vision to be a world class oncology company bringing targeted medicines to patients, says Dr. Nathan Yoganathan, President and Chief Scientific Officer at KalGene. We are developing precision medicine tools that provide more effective cancer...

2014-06-12 12:27:01

Health Briefs features new technologies by GENEWIZ, Inc. that support personalized medicine. CORAL SPRINGS, Fla., June 12, 2014 /PRNewswire-iReach/ -- The producers of Health Briefs with Terry Bradshaw are pleased to announce that GENEWIZ, Inc. will be featured in an upcoming segment on "Improving Treatment Outcomes through Innovative Technology" as part of the show's Future of Healthcare series. Logo - http://photos.prnewswire.com/prnh/20140611/117231 Moving away from the...

2014-06-10 12:26:08

PORTLAND, Oregon, June 10, 2014 /PRNewswire/ -- According to a new research report by Allied Market Research titled "Global Companion Diagnostic Market (Indications, Technologies and Geography) - Industry Analysis, Trends, Share, Opportunities and Forecast, 2013 - 2020", the global companion diagnostic market is expected to reach $3.5 billion by 2020, and it would grow at a CAGR of 20% from 2014 to 2020. North America was the highest revenue generating region in 2013 and would...

2014-06-10 08:30:04

--Study in Nature Genetics Used PGDx Exome Analysis to Identify Previously Unknown Mutation with Potential as New Drug Target for Lethal Childhood Brain Cancer-- BALTIMORE, June 10, 2014 /PRNewswire/ -- Personal Genome Diagnostics Inc. (PGDx), a provider of advanced cancer genome analysis and testing services, reported that its exome analysis services played a central role in several cancer studies recently published in leading scientific journals. PGDx's exome analysis...

2014-06-09 08:28:20

Large amounts of information generated by gene expression profiling will increase implementation of data management tools LONDON, June 9, 2014 /PRNewswire/ -- Gene expression profiling can bring significant improvements to disease profiling and diagnoses based on genetic disposition. Recent technology advances in this area are in fact enabling personalized medicine, where physicians provide patients with tailor-made treatment plans to fight diseases. Cases of cancer, cardiovascular...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.